Building on the success of the Pharma and Life Sciences Summit at HLTH Europe 2025, the exclusive one day global pharma summit gives senior industry leaders the opportunity to step out of operational cycles and address head-on the forces that will define the industry’s next decade.
It offers a strategic view of how scientific progress, regulatory shifts, competition, and market dynamics shape decisions that drive pipeline strength and commercial performance.
Join 250+ senior leaders to inform your decisions, make the right connections, and surface real opportunities.
We’re convening the key players of life sciences – C-suite leaders from pharma and biotech, top regulators, and senior innovators – for an exclusive, behind-closed-doors gathering.
C-suite and senior executives from global pharma and leading life sciences companies who steer portfolio strategy, investment decisions, and long-term enterprise direction.
Senior leaders responsible for shaping product strategy across the lifecycle, from generating evidence and engaging scientific communities to navigating pricing, access, and the commercial execution required for successful global launches.
Influential voices shaping the policy and regulatory frameworks that govern how innovation advances from early development to approval, access, and adoption.
Senior leaders and innovators from technology, AI, investment, who bring new approaches and partnership models that accelerate life sciences innovation.
sponsors backing the Summit
countries across every major European market
leading pharma organisations
senior attendees shaping global strategy
C-suite
Understand how shifts in science, policy, markets, and technology are shaping pharma’s next decade.
Explore collaborations with senior leaders across pharma, policy, technology, and investment in a focused, high-level environment.
See how new approaches in AI, evidence generation, and clinical development are influencing decisions from discovery to commercialisation.
Build meaningful connections with decision-makers who influence portfolio direction, policy, market access, and enterprise strategy.
Lu Zheng
VP, Head of Digital Health
Takeda Pharmaceuticals
